Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 22, 2025 • 2:01 PM ET

Date/Time Source News Release
01/21/2025 07:30 AM EST Business Wire Atara Biotherapeutics Provides Update on Clinical Programs Related to EBVALLO(TM) (tabelecleucel) and ATA3219
01/16/2025 08:30 AM EST Business Wire Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)
12/04/2024 07:00 AM EST GlobeNewswire Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now
11/27/2024 04:01 PM EST Business Wire Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference
11/13/2024 04:01 PM EST Business Wire Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference
11/12/2024 04:01 PM EST Business Wire Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress
11/05/2024 04:01 PM EST Business Wire Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
10/04/2024 04:01 PM EDT Business Wire Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/06/2024 04:01 PM EDT Business Wire Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/04/2024 04:01 PM EDT Business Wire Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Page